Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Angiologia ; 45(5): 177-9, 1993.
Artigo em Espanhol | MEDLINE | ID: mdl-8285365

RESUMO

We report 72 non-diabetic patients with obliterant atherosclerosis, stadium II, (intermittent claudication). The medium age of these patients was 62 +/- 4.5 years old. They were randomly included into four groups. Three were treated with Ozone: one of them by endovenous way, other intramuscular way, and the last one by rectal way; meanwhile, in the fourth group the patients were submitted to conventional medical treatment (control group). In the three ozone-groups there weren't differences when they were compared between then. But there was a significant improvement in comparison with the control group. The claudication distance in the treadmill increased to the 2.5 km/hour. Ankle/arm pressure rates hadn't significant differences, this corroborates the ozone action on the microcirculation. The least uncomfortable, the more harmless and the more economic way was the rectal way.


Assuntos
Arteriosclerose Obliterante/tratamento farmacológico , Ozônio/administração & dosagem , Arteriosclerose Obliterante/fisiopatologia , Hemodinâmica/efeitos dos fármacos , Humanos , Claudicação Intermitente/tratamento farmacológico , Claudicação Intermitente/fisiopatologia , Pessoa de Meia-Idade , Indução de Remissão
2.
Angiologia ; 45(4): 146-8, 1993.
Artigo em Espanhol | MEDLINE | ID: mdl-8239044

RESUMO

Fifteen patients with atherosclerosis obliterans at the lower limbs, no candidates to revascularizing surgery were submitted to ozone therapy. An improvement statistically significant was noticed in the treatment groups since amputation ratio decreased (26.7%) and the need of pain's surgery procedures (13.3%) in comparison with the control group (46.7 and 26.7% respectively). Ozone therapy is considered as a good way in the management of the atherosclerosis with obliteration in late period.


Assuntos
Arteriosclerose Obliterante/terapia , Ozônio/administração & dosagem , Idoso , Idoso de 80 Anos ou mais , Arteriosclerose Obliterante/fisiopatologia , Transfusão de Sangue Autóloga/métodos , Terapia Combinada , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA